(Q52296766)

28 April 2018

title

Gamma-hydroxybutyric acid in alcohol preference, dependence and withdrawal. (English)

1 reference

28 April 2018

author name string

G Colombo

series ordinal

1

1 reference

28 April 2018

G L Gessa

series ordinal

2

1 reference

28 April 2018

publication date

1 October 2000

1 reference

28 April 2018

published in

Addiction Biology

1 reference

28 April 2018

volume

5

1 reference

28 April 2018

issue

4

1 reference

28 April 2018

page(s)

389-403

1 reference

28 April 2018

Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Conversion in vivo of γ-aminobutyric to γ-hydroxybutyric acid in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

High affinity binding sites for gamma-hydroxybutyric acid in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyric acid binding sites in rat and human brain synaptosomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Conversion of 1,4-butanediol to -hydroxybutyric acid in rat brain and in peripheral tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Regional differences in depolarization-induced release of gamma-hydroxybutyrate from rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

gamma-Hydroxybutyrate uptake by rat brain striatal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Significance of gamma-hydroxybutyric acid in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyrate: an overview of the pros and cons for it being a neurotransmitter and/or a useful therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Anti-sedative and anti-cataleptic properties of NCS-382, a γ-hydroxybutyrate receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

High sensitivity to gamma-hydroxybutyric acid in ethanol-preferring sP rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The addition of clonidine to prilocaine for intravenous regional anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs. propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Neurogenetic adaptive mechanisms in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Circadian drinking pattern of Sardinian alcohol-preferring rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Sardinian alcohol-preferring rats: a genetic animal model of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Animal models for assessing drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

The biological, social and clinical bases of drug addiction: commentary and debate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Clinical course of gamma-hydroxybutyrate overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Abuse and therapeutic potential of gamma-hydroxybutyric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

"Grievous bodily harm:" gamma hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

Coma-inducing drug GHB may be reclassified.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1369-1600.2000.TB00207.X

10.1111/J.1369-1600.2000.TB00207.X

21 January 2018

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018